Table: Fuji Pharmaceutical -Q1 group results

Fuji Pharma

06/02/2020 07:30

Feb 6 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Dec 31, 2019        Dec 31, 2018     Sep 30, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             8.97                10.28            33.83    
                 (-12.7 pct)         (+3.2 pct)       (-6.8 pct)  
  Operating         1.05                 1.61             2.57    
                 (-34.4 pct)         (-7.0 pct)       (-38.4 pct) 
  Recurring         1.09                 1.53             2.50    
                 (-29.1 pct)         (-16.0 pct)      (-40.0 pct) 
  Net              745 mln               1.10             1.66    
                 (-32.0 pct)         (-15.8 pct)      (-43.8 pct) 
  EPS             23.92 yen           36.63 yen        53.44 yen  
  Ann Div                             29.00 yen        29.00 yen  
  -Q2 div                             14.00 yen        14.00 yen  
  -Q4 div                             15.00 yen        15.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T